3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Respiratory Problems -

Viagra may be useful for serious lung disease

Respiratory ProblemsNov 19, 05

Treatment with Viagra (sildenafil) can improve exercise capacity and functional ability in patients with pulmonary arterial hypertension, a serious disease involving high pressure in the blood vessels that enter the lungs, new research suggests.

The findings, which appear in The New England Journal of Medicine, are based on a study of 278 patients who were randomly selected to receive Viagra, at one of three doses, or inactive “placebo” three times daily for 12 weeks.

The main endpoint was the distance walked in 6 minutes. According to the report, the study did not have enough patients to assess the effect of Viagra on the risk of death.

At all of the doses tested, Viagra significantly improved the 6-minute walking distance when compared with placebo, lead author Dr. Nazzareno Galie, from the University of Bologna in Italy, and colleagues note. For the 222 patients who used Viagra for 1 year, the improvement in distance was 51 meters.

In addition, all of the Viagra doses were associated with a significant drop in lung blood pressure and with an improvement in functional ability.

Consistent with previous reports, side effects, such as flushing and diarrhea, were more common with Viagra than with placebo, the findings indicate.

“This study demonstrates the efficacy and safety of sildenafil in the treatment of patients with symptomatic pulmonary artery hypertension,” the researchers conclude. However, as noted, the study was not designed to assess Viagra’s effect on the risk of death.

The study was funded by Pfizer, Inc., which markets Viagra.

SOURCE: The New England Journal of Medicine, November 17, 2005.

Print Version
comments powered by Disqus

  Study shows treatment for genetically caused emphysema is effective
  New method enables drug target validation for COPD treatment
  Garlic extract could help cystic fibrosis patients fight infection
  New technique provides novel approach to diagnosing ciliopathies
  Innovative Experiment Aims to Boost Lung Transplants
  CPAP improves work productivity for sleep apnea patients
  New Mayo Software Identifies and Stratifies Risk Posed by Lung Nodules
  Researchers explore PKC role in lung disease
  Breathing program may held save newborns’ lives: studies
  Vitamin D Improves Exercise Outcomes in Patients with COPD
  CPAP improves daytime sleepiness even in patients with low levels of symptoms
  Anti-Clotting Agent Does Not Improve Outcomes of Patients with Severe Pneumonia


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site